Signaling and Antiproliferative Effects of Type I and II Gonadotropin-Releasing Hormone Receptors in Breast Cancer Cells

Craig A. McArdle(University of Bristol), Lisa Green(Wellcome Trust), James N. Hislop(University of California, San Francisco), Eamonn Kelly(University of Bristol)
The Journal of Clinical Endocrinology & Metabolism
April 1, 2004
10.1210/jc.2003-030787
Cited by 33

Related Papers

The Concise Guide to PHARMACOLOGY 2015/16: G protein‐coupled receptors
|British Journal of Pharmacology|2015|849
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors
|British Journal of Pharmacology|2019|712
The Concise Guide to PHARMACOLOGY 2015/16: Enzymes
|British Journal of Pharmacology|2015|603
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes
|British Journal of Pharmacology|2017|597
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein‐coupled receptors
|British Journal of Pharmacology|2017|589